US Food and Drug Administration approval of esketamine and brexanolone
- PMID: 31680013
- DOI: 10.1016/S2215-0366(19)30292-5
US Food and Drug Administration approval of esketamine and brexanolone
Comment in
-
In with the new?Lancet Psychiatry. 2019 Dec;6(12):967. doi: 10.1016/S2215-0366(19)30445-6. Lancet Psychiatry. 2019. PMID: 31777341 No abstract available.
-
Approval of esketamine for treatment-resistant depression.Lancet Psychiatry. 2020 Mar;7(3):232-235. doi: 10.1016/S2215-0366(19)30533-4. Lancet Psychiatry. 2020. PMID: 32087801 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

